A retrospective study on the efficacy and safety of donafenib combined with transarterial chemoembolization (TACE) and with/without immunotherapy in intermediate-advanced hepatocellular carcinoma (HCC).

被引：0
|
作者：
Chen, Cong
Fu, Shouzhong
Zhao, Suming
Yuan, Hongxin
Dai, Feng
Gu, Weiwei
Gu, Zhuxin
Shi, Rongfeng
Yang, Xiaohu
Lu, Xiaohua
Jia, Pengfei
Si, Luyi
Zhao, Hui
机构：
[1] Affiliated Hosp Nantong Univ, Nantong, Peoples R China
[2] Nantong Univ, Nantong Peoples Hosp 3, Nantong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16171
引用
收藏
页数：1
相关论文
共 50 条
  • [31] The Role of Lipiodol in the Treatment of Hepatocellular Carcinoma (HCC) through Transarterial Chemoembolization (TACE)
    Popa, Bogdan Valeriu
    Bratu, Ana Magdalena
    Minoiu, Costin Aurelian
    Turculet, Claudiu
    Ene, Dragos
    Constantinescu, Gabriel
    Ilie, Madalina
    Popescu, Mina
    Badila, Elisabeta
    REVISTA DE CHIMIE, 2015, 66 (03): : 408 - 412
  • [32] Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma
    Wenbin Liu
    Zhiguo Xie
    Kefeng Shen
    Lizhu Jiang
    Chongyan Liu
    Yongsheng Ge
    Jihai Yu
    Weidong Jia
    Jinliang Ma
    Hao Chen
    Medical Oncology, 40
  • [33] Transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC): No need for antibiotic prophylaxis.
    Andriulli, A
    Modola, G
    Lezzi, G
    Siena, D
    Conoscitore, P
    Nardella, G
    Facciorusso, D
    Mangia, A
    Giacobbe, A
    GASTROENTEROLOGY, 1997, 112 (04) : A532 - A532
  • [34] TACE-HAIC combined with donafenib and immunotherapy for hepatocellular carcinoma (HCC) with portal vein tumour thrombus (PVTT): A retrospective analysis.
    Yin, Linan
    Liu, Ruibao
    Hou, Xunbo
    Lu, Junrong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] Analysis of the safety and effectiveness of TACE combined with targeted immunotherapy in the treatment of intermediate and advanced hepatocellular carcinoma
    Liu, Wenbin
    Xie, Zhiguo
    Shen, Kefeng
    Jiang, Lizhu
    Liu, Chongyan
    Ge, Yongsheng
    Yu, Jihai
    Jia, Weidong
    Ma, Jinliang
    Chen, Hao
    MEDICAL ONCOLOGY, 2023, 40 (09)
  • [36] Hepatocellular carcinoma (HCC): ART-score and retreatment with transarterial chemoembolization (TACE)
    Dionisio de Sousa, I. J.
    Rodrigues, J.
    Pais, A.
    Bonito, N.
    Jacinto, P.
    Marques, M.
    Ribeiro, J.
    Figueiredo, P.
    Gervasio, H.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S420 - S421
  • [37] Sunitinib and Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma (HCC)- Final Results of a Phase 2 Trial
    Iyer, R.
    Fetterly, G.
    Groman, A.
    Hutson, A.
    Khushalani, N.
    Mohile, S.
    Ashton, E.
    Litwin, A.
    Grande, C.
    Tomaszewski, G.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S447 - S447
  • [38] Trial Results for Sunitinib and Transarterial Chemoembolization (TACE) in Inoperable Hepatocellular Carcinoma (HCC)
    Wu, Y. V.
    Tomaszewski, G. M.
    Fetterly, G. J.
    Kuvshinoff, B.
    Groman, A.
    Wilkinson, N. W.
    Khushalani, N. I.
    Iyer, R. V.
    ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S114 - S115
  • [39] FACTORS AFFECTING OUTCOMES AFTER TRANSARTERIAL CHEMOEMBOLIZATION (TACE) FOR HEPATOCELLULAR CARCINOMA (HCC)
    Suman, A.
    Sharma, A.
    Venkataperumal, S.
    Limaye, A.
    Morelli, G.
    Clark, V.
    Soldevila-Pico, C.
    Cabrera, R.
    Firpi, R.
    Nelson, D.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S395 - S395
  • [40] EFFICACY OF HIGH-DOSE CONFORMAL RADIOTHERAPY (CRT) COMBINED TO TRANSARTERIAL CHEMOEMBOLIZATION (TACE) FOR SINGLE HEPATOCELLULAR CARCINOMA (HCC) NODULE
    Merle, Philippe
    Cuinet, Marie
    Marion, Denis
    Maillard, Emmanuel
    Wautot, Virginie
    Trepo, Christian
    Zoulim, Fabien
    Mornex, Francoise
    HEPATOLOGY, 2009, 50 (04) : 1078A - 1078A
12345